Genmab — Juni 2019

[E_L]

Relapse Therapies also interesting , a bit on Isa and Dara https://www.myeloma.org/videos/relapse-therapies-imwg-amsterdam-2019

[E_L]

“With Dara coming earlier…. Where Isa is gonna fit is a little bit chalenging , because, to be honest, almost everybody will have had Daratumumab, if not in frontline then first relapse. And we dont really know how effective Isa is once you failed Dara.”

[Bulder]

Noted that there is a developement going on with sc isa!

[Bulder]

and thx for those 2 videos E L

[Hen]

Investtech-analysevideo fra i går: https://play.borsen.dk/klip/5d073ad3595ab4f00a333654

[E_L]

yes, he also said 'it won't be as quickly as daratumumab obviously', not sure why. Anyway, currently the speed is 1 of Isa's few advantages; that will disappear with Dara SC

[E_L]

it is funny how these doctors speak as if it is already approved sometimes... ("now that we have SC"...)

[E_L]

i also thought it was interesting them talking about Dara monthly maintenance possibly switching back to weekly in case of deterioration

[Bulder]

Maybe they already started off label .- it's not a new drug, only way of adm.

[E_L]

yes, maybe. Rajkumar sort of seemed to imply that also with D-VRd and D-VTd. Will be interesting to see US volume later this year...

[LyngeInv]

Fra Medwatch: Det tyske biotekselskab Biontech er sammen med Genmab klar til det første forsøg i mennesker med et lægemiddel, som de to selskaber udvikler i fællesskab.

[E_L]

another example of off-label? https://twitter.com/SchutzNatalia/status/1140976374464831488

[AaBforever]

Ser ud til det bliver en okay dag i dag..:-)

[Vitus]

Nå nå AaB....nu ikke for optimistisk ...vi er vel nordjyder

[Darvin]

Han skrev “okay” ikke god eller
super

[AaBforever]

God skal vi over 1300...super skal vi over 1400...:-D

[Vitus]

Enig AaB .....

[bibob]

Jow, det går da nogenlunde.

[Darvin]

Det er da et bette skridt på vejen - så det!

[Vitus]

Champagnen skal nok ikke på køl i dag